Skip to contentE
Electromedical Technologies, Inc
E
EMEDElectromedical Technologies, Inc Q4 2022 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$423.15K$423.15Kderived+78.7% vs Q4 2021 Net Income-$830.09K-$830.09KderivedN/M vs Q4 2021 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Electromedical Technologies, Inc · CIK 1715819 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$332,929+70.2% Operating Incomederived-$257,332N/M Operating Cash Flowderived-$33,099N/M Margins · derivedGross margin78.7%−3.9 pt vs Q4 2021
Operating margin-60.8%+568.6 pt vs Q4 2021
Net margin-196.2%+583.1 pt vs Q4 2021
ended Dec 31, 2022 · filed Mar 31, 2023 · 90 d after period end